VADASTUXIMAB

UNII:	OQE503T586
Formula:
Preferred Substance Name:	VADASTUXIMAB
GSRS Full Record:	OQE503T586 i

1436390-63-4
H2H12EC
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 3) (HUMAN-MUS MUSCULUS MONOCLONAL H2H12EC HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL H2H12EC LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD33 (SIALIC ACID BINDING IG-LIKE LECTIN 3, SIGLEC3, SIGLEC-3, GP67, P67)), CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-447) (MUS MUSCULUS VH (IGHV1- 85*01 -(IGHD) -IGHJ4*01) (8.8.10) (1-117) -HOMO SAPIENS IGHG1*01, GM17,1 (CH1 (118-215), HINGE (216-230), CH2 S3>C (239) (231-340),CH3 (341-445), CHS (446-447)) (118-447)), (220-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'- 214') (MUS MUSCULUS V-KAPPA (IGKV14-111*01 - IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01, KM3 (108'-214')) DIMER (226-226'':229-229'')-BISDISULFIDE
VADASTUXIMAB [INN]
VADASTUXIMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VADASTUXIMAB

Synonyms and Mappings

Resources